Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,599.96
(
0.26%
)
US TECH 100
29,611.20
(
0.27%
)
Dow Jones
51,078.88
(
0.09%
)
Brent Oil
93.44
(
-2.64%
)
Bitcoin
70,234.00
(
-1.59%
)
News Focus
News Focus
Post# of 519040
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Bourbon_on_my_cornflakes

Send PM Follow Ignore
Followers 60
Posts 11415
Boards Moderated 0
Alias Born 01/31/2008

Bourbon_on_my_cornflakes

Re: sage4 post# 496397

Tuesday, 08/05/2025 5:56:24 PM

Tuesday, August 05, 2025 5:56:24 PM

Post# of 519040
It is possible if 273 approved for multiple indications where mitochondrial malfunction is a problem.
Alz, Parkinsons, and all the other CNS diseases
also the cardio applications for which it was patented.
and if 371 has epic results for schizo, and follow on success with other CNS.
We could end up the CNS global powerhouse.
But first, we need to get one approval in the end zone!

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News